TabsDetailsBasic DetailsDate Posted: Thursday, September 3, 2020Status: CompleteMedical Product: ranitidineDescription: In this request we assessed the use patterns of ranitidine and a comparator agent, famotidine, within the Sentinel Distributed Database (SDD). This request contains two reports. Report 1 includes data only from the Centers for Medicare and Medicaid Services (CMS) Data Partner, representing patients with Medicare fee-for-service coverage. The study period includes data from January 1, 2010 through December 31, 2018.Report 2 includes data from all Sentinel Data Partners except CMS. The study period includes data from January 1, 2000 through April 30, 2019.We distributed this request to 17 Sentinel Data Partners on October 28, 2019. Read More Deliverables (2)Sentinel Modular Program Report: Ranitidine Drug Utilization Patterns, Report 1Sentinel Modular Program Report: Ranitidine Drug Utilization Patterns, Report 2Additional InformationAdditional DetailsFDA Center: CDERTime Period: January 1, 2000 - April 30, 2019Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Sentinel Distributed Database (SDD)